Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Melatonin in Peripheral Nerve Regeneration: Molecular Mechanisms, Schwann Cell Dynamics, and Translational Therapeutic Potential.
A Recurrent and Atypical Form of Guillain-Barré Syndrome: A Case Report.
Artificial intelligence and machine learning in neurogenic lower urinary tract dysfunction and spinal cord injury: current status, emerging technologies, and ethical perspectives.
Multiancestry genome-wide association and multiomics analyses elucidate spatiocellular features of multiple sclerosis genetics.
Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system.
AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)-A Comprehensive Neurological Protocol From a Single MRI Scan.
[Criteria for choosing treatment of multiple sclerosis].
Response to "comment on 'evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders'".
Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis.
Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
Cannabinoids in autoimmune diseases: mechanistic insights and translational challenges.
Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.
Should autologous HSCT be a first-line option in highly active MS? Commentary.
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.
Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis.
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
Guillain-Barré Polyradiculoneuritis Developed in the Context of Lyme Neuroborreliosis in a 13-Year-Old Girl: A Case Report.
Central Pontine Myelinolysis Leading to an Intensive Care Unit Admission.
Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with Multiple Sclerosis: A T1 mapping study.
The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging.
Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist.
The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability.
Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis.
Cell type transcriptomic modules reveal shared molecular mechanisms in Alzheimer's and Parkinson's disease.
A multi-omics atlas reveals spatially resolved sphingolipid metabolic reprogramming after spinal cord injury.
Pages
« first
‹ previous
…
879
880
881
882
883
884
885
886
887
…
next ›
last »